Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
BioMarin Pharmaceutical Inc. - Common Stock
(NQ:
BMRN
)
51.81
-1.43 (-2.69%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 15, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
2,076,143
Open
53.41
Bid (Size)
51.95 (100)
Ask (Size)
53.00 (500)
Prev. Close
53.24
Today's Range
51.68 - 53.41
52wk Range
50.76 - 66.28
Shares Outstanding
183,352,255
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
2 Cash-Producing Stocks Worth Investigating and 1 We Turn Down
May 14, 2026
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. Cas...
Via
StockStory
Topics
Credit Cards
BioMarin Pharmaceutical’s Q1 Earnings Call: Our Top 5 Analyst Questions
May 11, 2026
BioMarin’s first quarter saw revenue growth driven by continued demand for its enzyme therapies and Voxzogo, but the company missed Wall Street’s revenue and...
Via
StockStory
Topics
Earnings
Performance
YTD
-12.9%
-12.9%
1 Month
-6.6%
-6.6%
3 Month
-13.6%
-13.6%
6 Month
-4.4%
-4.4%
1 Year
-11.7%
-11.7%
More News
Read More
BMRN Q1 Deep Dive: Amicus Acquisition, Pipeline Milestones, and Order Dynamics Shape Outlook
May 05, 2026
Via
StockStory
BioMarin (BMRN) Q1 2026 Earnings Transcript
↗
May 04, 2026
Via
The Motley Fool
BioMarin Pharmaceutical Inc (NASDAQ:BMRN) Q1 Earnings Miss Masked by Raised 2026 Guidance
↗
May 04, 2026
Via
Chartmill
Topics
Earnings
BioMarin Pharmaceutical (NASDAQ:BMRN) Misses Q1 CY2026 Revenue Estimates
May 04, 2026
Via
StockStory
BioMarin (BMRN) Q4 2025 Earnings Transcript
↗
May 04, 2026
Via
The Motley Fool
BioMarin Pharmaceutical (BMRN) Reports Earnings Tomorrow: What To Expect
May 02, 2026
Via
StockStory
Topics
Artificial Intelligence
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Emerges as a Compelling Value Stock
↗
April 17, 2026
Via
Chartmill
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Presents a Compelling Value Investment Case
↗
March 16, 2026
Via
Chartmill
Ascendis Pharma Completes Strategic Trifecta with U.S. Launch of YUVIWEL and Seven-Year Orphan Exclusivity
April 13, 2026
Via
MarketMinute
Topics
Economy
2 Profitable Stocks with Promising Prospects and 1 Facing Challenges
April 08, 2026
Via
StockStory
Hims & Hers Health, Regeneron, Biogen, BioMarin Pharmaceutical, and Moderna Shares Are Falling, What You Need To Know
April 02, 2026
Via
StockStory
Topics
Government
Stocks
World Trade
Ultragenyx Vaults Toward Commercialization as FDA Accepts Landmark Gene Therapy BLA
April 02, 2026
Via
MarketMinute
Topics
Intellectual Property
Lawsuit
1 of Wall Street’s Favorite Stock with Promising Prospects and 2 We Find Risky
March 26, 2026
Via
StockStory
Biotech Stock Up 372% Gets Sold as New Pick Rises 40% in 2026
↗
March 20, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
This Biotech Stock Has Surged 250% in a Year as One Investor Discloses $10 Million New Position
↗
March 20, 2026
Via
The Motley Fool
Q4 Earnings Highlights: BioMarin Pharmaceutical (NASDAQ:BMRN) Vs The Rest Of The Therapeutics Stocks
March 19, 2026
Via
StockStory
Topics
Artificial Intelligence
This Investor Sold $104 Million of Nuvalent Stock Amid Cancer Drug Developer's Nearly 30% Rally
↗
March 16, 2026
Via
The Motley Fool
This Biotech Attracted a $181 Million Investment During a Staggering 1,300% Stock Rally
↗
March 16, 2026
Via
The Motley Fool
Hedge Fund Boone Capital Initiated a Stake in HealthEquity. Is the Stock a Buy?
↗
March 15, 2026
Via
The Motley Fool
2 Mid-Cap Stocks with Exciting Potential and 1 We Question
March 12, 2026
Via
StockStory
Investment Manager Bets Big on PTCT Stock, Adds 41,000 Shares, According to Recent SEC Filing
↗
March 03, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
2 Reasons to Like BMRN (and 1 Not So Much)
March 02, 2026
Via
StockStory
Investment Firm Adds Nearly $4 Milllion Worth of DYN Shares, According to Recent SEC Filing
↗
March 02, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
Frequently Asked Questions
Is BioMarin Pharmaceutical Inc. - Common Stock publicly traded?
Yes, BioMarin Pharmaceutical Inc. - Common Stock is publicly traded.
What exchange does BioMarin Pharmaceutical Inc. - Common Stock trade on?
BioMarin Pharmaceutical Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for BioMarin Pharmaceutical Inc. - Common Stock?
The ticker symbol for BioMarin Pharmaceutical Inc. - Common Stock is BMRN on the Nasdaq Stock Market
What is the current price of BioMarin Pharmaceutical Inc. - Common Stock?
The current price of BioMarin Pharmaceutical Inc. - Common Stock is 51.81
When was BioMarin Pharmaceutical Inc. - Common Stock last traded?
The last trade of BioMarin Pharmaceutical Inc. - Common Stock was at 05/15/26 04:00 PM ET
What is the market capitalization of BioMarin Pharmaceutical Inc. - Common Stock?
The market capitalization of BioMarin Pharmaceutical Inc. - Common Stock is 9.50B
How many shares of BioMarin Pharmaceutical Inc. - Common Stock are outstanding?
BioMarin Pharmaceutical Inc. - Common Stock has 9B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
